{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:59:23Z","timestamp":1791849563244,"version":"4.3.4"},"reference-count":130,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Membranous nephropathy (MN) is the most common cause of nephrotic syndrome among adults, which is the leading glomerular disease that recurs after kidney transplantation. Treatment for MN remained controversial and challenging, partly owing to absence of sensitive and specific biomarkers and effective therapy for prediction and diagnosis of disease activity. MN starts with the formation and deposition of circulating immune complexes on the outer area in the glomerular basement membrane, leading to complement activation. The identification of autoantibodies against the phospholipase A<jats:sub>2<\/jats:sub> receptor (PLA<jats:sub>2<\/jats:sub>R) and thrombospondin type-1 domain-containing protein 7A (THSD7A) antigens illuminated a distinct pathophysiological rationale for MN treatments. Nowadays, detection of serum anti-PLA<jats:sub>2<\/jats:sub>R antibodies and deposited glomerular PLA<jats:sub>2<\/jats:sub>R antigen can be routinely applied to MN. Anti-PLA<jats:sub>2<\/jats:sub>R antibodies exhibited much high specificity and sensitivity. Measurement of PLA<jats:sub>2<\/jats:sub>R in immune complex deposition allows for the diagnosis of PLA<jats:sub>2<\/jats:sub>R-associated MN in patients with renal biopsies. In the review, we critically summarized newer diagnosis biomarkers including PLA<jats:sub>2<\/jats:sub>R and THSD7A tests and novel promising therapies by using traditional Chinese medicines such as <jats:italic>Astragalus membranaceus<\/jats:italic>, <jats:italic>Tripterygium wilfordii<\/jats:italic>, and Astragaloside IV for the treatment of MN patients. We also described unresolved questions and future challenges to reveal the diagnosis and treatments of MN. These unprecedented breakthroughs were quickly translated to clinical diagnosis and management. Considerable advances of detection methods played a critical role in diagnosis and monitoring of treatment.<\/jats:p>","DOI":"10.3389\/fphar.2022.907108","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T06:48:07Z","timestamp":1653547687000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan-Ni","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1053\/j.ajkd.2007.07.032","article-title":"Treatment of Idiopathic Membranous Nephropathy with the Herb Astragalus Membranaceus","volume":"50","author":"Ahmed","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00467-013-2717-z","article-title":"Membranous Nephropathy: Not Just a Disease for Adults","volume":"30","author":"Ayalon","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5527\/wjn.v10.i2.21","article-title":"Siblings with Coronavirus Disease 2019 Infection and Opposite Outcome-The Hemodialysis's Better Outcome Paradox: Two Case Reports","volume":"10","author":"Bacharaki","year":"2021","journal-title":"World J. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1681\/ASN.2015101155","article-title":"Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency","volume":"27","author":"Bally","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000481635","article-title":"Membranous Nephropathy: Approaches to Treatment","volume":"47","author":"Bomback","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fmed.2020.00412","article-title":"Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial","volume":"7","author":"Brglez","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"734410","DOI":"10.3389\/fmed.2021.734410","article-title":"Changes of Brain Functional Connectivity in End-Stage Renal Disease Patients Receiving Peritoneal Dialysis without Cognitive Decline","volume":"8","author":"Chang","year":"2021","journal-title":"Front. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.tips.2018.09.002","article-title":"Natural Products as a Source for Antifibrosis Therapy","volume":"39","author":"Chen","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.phymed.2018.09.182","article-title":"Natural Products for the Prevention and Treatment of Kidney Disease","volume":"50","author":"Chen","year":"2018","journal-title":"Phytomedicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13063-020-4144-3","article-title":"Comparison of the Efficacy and Safety of Tacrolimus Monotherapy and Cyclophosphamide Combined with Glucocorticoid in the Treatment of Adult Primary Membranous Nephropathy: Protocol of a Multicenter, Randomized, Controlled, Open Study","volume":"21","author":"Chen","year":"2020","journal-title":"Trials"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1053\/j.ajkd.2013.05.005","article-title":"Efficacy and Safety of Traditional Chinese Medicine (Shenqi Particle) for Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Controlled Clinical Trial","volume":"62","author":"Chen","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/s41401-020-0475-6","article-title":"Polydatin Attenuates Renal Fibrosis in Diabetic Mice through Regulating the Cx32-Nox4 Signaling Pathway","volume":"41","author":"Chen","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5527\/wjn.v10.i6.109","article-title":"Efficacy and Safety of Recombinant Human Erythropoietin (Hema-Plus\u00ae) for Management of Anemia in Thai Patients on Peritoneal Dialysis","volume":"10","author":"Chuengsaman","year":"2021","journal-title":"World J. Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fmed.2019.00241","article-title":"Immune-monitoring Disease Activity in Primary Membranous Nephropathy","volume":"6","author":"Cravedi","year":"2019","journal-title":"Front. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"675406","DOI":"10.3389\/fphar.2021.675406","article-title":"Herbal Medicine \"Shulifenxiao\" Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy","volume":"12","author":"Cui","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3720591","DOI":"10.1155\/2018\/3720591","article-title":"Clinical Presentation, Outcomes, and Treatment of Membranous Nephropathy after Transplantation","volume":"2018","author":"da Silva","year":"2018","journal-title":"Int. J. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1681\/ASN.2016040449","article-title":"Rituximab for Severe Membranous Nephropathy: a 6-month Trial with Extended Follow-Up","volume":"28","author":"Dahan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cca.2013.03.015","article-title":"Development of a Standardized ELISA for the Determination of Autoantibodies against Human M-type Phospholipase A2 Receptor in Primary Membranous Nephropathy","volume":"421","author":"D\u00e4hnrich","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal Membranous Glomerulonephritis Due to Anti-neutral Endopeptidase Antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMc1011678","article-title":"PLA2R Autoantibodies and PLA2R Glomerular Deposits in Membranous Nephropathy","volume":"364","author":"Debiec","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"557368","DOI":"10.3389\/fcimb.2020.557368","article-title":"A Comparative Study of the Gut Microbiota Associated with Immunoglobulin a Nephropathy and Membranous Nephropathy","volume":"10","author":"Dong","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41401-021-00620-9","article-title":"Natural Products: Potential Treatments for Cisplatin-Induced Nephrotoxicity","volume":"42","author":"Fang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"B24","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3389\/fphar.2020.00994","article-title":"How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?","volume":"11","author":"Feng","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.kint.2020.10.014","article-title":"The STARMEN Trial Indicates that Alternating Treatment with Corticosteroids and Cyclophosphamide Is Superior to Sequential Treatment with Tacrolimus and Rituximab in Primary Membranous Nephropathy","volume":"99","author":"Fern\u00e1ndez-Ju\u00e1rez","year":"2021","journal-title":"Kidney Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"795216","DOI":"10.3389\/fmed.2021.795216","article-title":"Case Report: Homozygous Pathogenic Variant P209L in the TTC21B Gene: a Rare Cause of End Stage Renal Disease and Biliary Cirrhosis Requiring Combined Liver-Kidney Transplantation. A Case Report and Literature Review","volume":"8","author":"Gambino","year":"2021","journal-title":"Front. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"663680","DOI":"10.3389\/fmed.2021.663680","article-title":"Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort","volume":"8","author":"Gao","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ekir.2020.12.035","article-title":"Rituximab in Membranous Nephropathy","volume":"6","author":"Gauckler","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41401-019-0324-7","article-title":"Ganoderic Acid Hinders Renal Fibrosis via Suppressing the TGF-\u03b2\/Smad and MAPK Signaling Pathways","volume":"41","author":"Geng","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5527\/wjn.v8.i7.109","article-title":"Broad Spectrum of Interferon-Related Nephropathies-Glomerulonephritis, Systemic Lupus Erythematosus-like Syndrome and Thrombotic Microangiopathy: A Case Report and Review of Literature","volume":"8","author":"Gianassi","year":"2019","journal-title":"World J. Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/biom11040513","article-title":"Mechanisms of Primary Membranous Nephropathy","volume":"11","author":"Gu","year":"2021","journal-title":"Biomolecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/ndt\/gfy049","article-title":"Rituximab versus the Modified Ponticelli Regimen in the Treatment of Primary Membranous Nephropathy: a Health Economic Model","volume":"33","author":"Hamilton","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"B34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ekir.2019.12.006","article-title":"Rituximab in Patients with Phospholipase A2 Receptor-Associated Membranous Nephropathy and Severe CKD","volume":"5","author":"Hanset","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41401-021-00788-0","article-title":"Ginsenoside Rb1 Alleviates Diabetic Kidney Podocyte Injury by Inhibiting Aldose Reductase Activity","volume":"43","author":"He","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"B36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3181\/00379727-100-24736","article-title":"Production of Nephrotic Syndrome in Rats by Freund's Adjuvants and Rat Kidney Suspensions","volume":"100","author":"Heymann","year":"1959","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"B37","first-page":"109","article-title":"Anti-PLA\u2082R Antibodies in Membranous Nephropathy: Ready for Routine Clinical Practice?","volume":"70","author":"Hofstra","year":"2012","journal-title":"Neth J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2016010050","article-title":"An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-specific Antibodies in Membranous Nephropathy","volume":"28","author":"Hoxha","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy","volume":"25","author":"Hoxha","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMc1511702","article-title":"A Mechanism for Cancer-Associated Membranous Nephropathy","volume":"374","author":"Hoxha","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"657232","DOI":"10.3389\/fmed.2021.657232","article-title":"M2 Macrophage Subpopulations in Glomeruli Are Associated with the Deposition of IgG Subclasses and Complements in Primary Membranous Nephropathy","volume":"8","author":"Hu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1111\/bph.15054","article-title":"A Practical Guide for Transparent Reporting of Research on Natural Products in the British Journal of Pharmacology: Reproducibility of Natural Product Research","volume":"177","author":"Izzo","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.3892\/mmr.2020.11014","article-title":"Advances of the Experimental Models of Idiopathic Membranous Nephropathy (Review)","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1113\/EP087190","article-title":"Down-regulation of the Long Non-coding RNA XIST Ameliorates Podocyte Apoptosis in Membranous Nephropathy via the miR-217-TLR4 Pathway","volume":"104","author":"Jin","year":"2019","journal-title":"Exp. Physiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e18970","DOI":"10.1097\/MD.0000000000018970","article-title":"Tripterygium Wilfordii Multiglycosides Combined with Prednisone in the Treatment of Idiopathic Membranous Nephropathy: A Protocol for a Systematic Review and Meta-Analysis","volume":"99","author":"Jin","year":"2020","journal-title":"Med. Baltim."},{"key":"B46","first-page":"313","article-title":"Nephrotic Glomerulonephritis","volume":"33","author":"Jones","year":"1957","journal-title":"Am. J. Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/jcm10122624","article-title":"Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy","volume":"10","author":"Jurubit\u0103","year":"2021","journal-title":"J. Clin. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1073\/pnas.79.18.5557","article-title":"The Pathogenic Antigen of Heymann Nephritis Is a Membrane Glycoprotein of the Renal Proximal Tubule Brush Border","volume":"79","author":"Kerjaschki","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/imna.imna_17_21","article-title":"The Yin and Yang Role of Transforming Growth Factor-\u03b2 in Kidney Disease","volume":"8","author":"Lan","year":"2021","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2478\/jtim-2020-0002","article-title":"Research Progress in the Treatment of Idiopathic Membranous Nephropathy Using Traditional Chinese Medicine","volume":"8","author":"Lang","year":"2020","journal-title":"J. Transl. Int. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3389\/fphar.2020.01080","article-title":"Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-\u039ab\/nlrp3 Pathway","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"606689","DOI":"10.3389\/fphar.2020.606689","article-title":"Integrated Fecal Microbiome and Serum Metabolomics Analysis Reveals Abnormal Changes in Rats with Immunoglobulin A Nephropathy and the Intervention Effect of Zhen Wu Tang","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"623489","DOI":"10.3389\/fphar.2020.623489","article-title":"Tangshen Formula Attenuates Diabetic Kidney Injury by Imparting Anti-pyroptotic Effects via the TXNIP-NLRP3-GSDMD axis","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"719880","DOI":"10.3389\/fphar.2021.719880","article-title":"Targeting the Wnt\/\u03b2-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"152913","DOI":"10.1016\/j.phymed.2019.152913","article-title":"Zhen-Wu-tang Ameliorates Membranous Nephropathy Rats through Inhibiting NF-\u039ab Pathway and NLRP3 Inflammasome","volume":"59","author":"Liu","year":"2019","journal-title":"Phytomedicine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3389\/fimmu.2020.01846","article-title":"Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41401-021-00721-5","article-title":"Wogonin Protects Glomerular Podocytes by Targeting Bcl-2-Mediated Autophagy and Apoptosis in Diabetic Kidney Disease","volume":"43","author":"Liu","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"B58","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000505175","article-title":"Membranous Nephropathy in Pregnancy","volume":"51","author":"Liu","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.ekir.2021.04.002","article-title":"Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy","volume":"6","author":"Logt","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ckj\/sfv049","article-title":"Glomerular IgG Subclasses in Idiopathic and Malignancy-Associated Membranous Nephropathy","volume":"8","author":"L\u00f6nnbro-Widgren","year":"2015","journal-title":"Clin. Kidney J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"6813760","DOI":"10.1155\/2020\/6813760","article-title":"Wenyang Lishui Decoction Ameliorates Podocyte Injury in Membranous Nephropathy Rat and Cell Models by Regulating P53 and Bcl-2","volume":"2020","author":"Lu","year":"2020","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0251131","DOI":"10.1371\/journal.pone.0251131","article-title":"Traditional Chinese Medicine as an Adjunct Therapy in the Treatment of Idiopathic Membranous Nephropathy: A Systematic Review and Meta-Analysis","volume":"16","author":"Lu","year":"2021","journal-title":"PLoS One"},{"key":"B63","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3892\/mmr.2022.12706","article-title":"Salivary Microbiota Analysis of Patients with Membranous Nephropathy","volume":"25","author":"Luan","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"800522","DOI":"10.3389\/fphar.2021.800522","article-title":"Shenkang Injection and its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting I\u0199B\/NF-\u0198b and Keap1\/Nrf2 Signaling Pathways","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.xkme.2018.12.003","article-title":"Use of Repository Corticotropin Gel (Acthar) in Progressive Nephrotic Syndrome Secondary to Transplant Glomerulopathy: a Report of Three Cases","volume":"1","author":"Markell","year":"2019","journal-title":"Kidney Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ndt\/gfr220","article-title":"Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Outcome in the Era of Evidence-Based Therapy","volume":"27","author":"McQuarrie","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1681\/ASN.2017010027","article-title":"New Insights into the Immunity and Podocyte in Glomerular Health and Disease: From Pathogenesis to Therapy in Proteinuric Kidney Disease","volume":"28","author":"Medina Rangel","year":"2021","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"B68","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41401-019-0329-2","article-title":"Ganoderic Acid A Is the Effective Ingredient of Ganoderma Triterpenes in Retarding Renal Cyst Development in Polycystic Kidney Disease","volume":"41","author":"Meng","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1111\/bph.15062","article-title":"Identification of Endogenous 1-aminopyrene as a Novel Mediator of Progressive Chronic Kidney Disease via Aryl Hydrocarbon Receptor Activation","volume":"177","author":"Miao","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bph.15705","article-title":"1-Hydroxypyrene Mediates Renal Fibrosis through Aryl Hydrocarbon Receptor Signalling Pathway","volume":"179","author":"Miao","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/ajt.16813","article-title":"Antiphospholipase A2 Receptor Antibody-Positive Membranous Nephropathy in the Kidney Donor: Lessons from a Serendipitous Transplantation","volume":"22","author":"Molina And\u00fajar","year":"2022","journal-title":"Am. J. Transpl."},{"key":"B72","doi-asserted-by":"publisher","first-page":"611317","DOI":"10.3389\/fmed.2020.611317","article-title":"Secondary Membranous Nephropathy. A Narrative Review","volume":"7","author":"Moroni","year":"2020","journal-title":"Front. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3390\/jcm10061205","article-title":"Membranous Nephropathy: from Research Bench to Personalized Care","volume":"10","author":"Moszczuk","year":"2021","journal-title":"J. Clin. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"108729","DOI":"10.1016\/j.clim.2021.108729","article-title":"Comparison of 3 Anti-pla2r Inmmunoassaysfor the Diagnosis of Idiopathic Membranous Nephropathy in an European Population. A Pilot Study","volume":"227","author":"Nieto-Ga\u00f1\u00e1n","year":"2021","journal-title":"Clin. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3389\/fimmu.2019.01326","article-title":"Membranous Nephropathy (MN) Recurrence after Renal Transplantation","volume":"10","author":"Passerini","year":"2019","journal-title":"Front. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40620-020-00888-w","article-title":"Diagnostic Accuracy of Anti-phospholipase A2 Receptor (PLA2R) Antibodies in Idiopathic Membranous Nephropathy: an Italian Experience","volume":"34","author":"Porcelli","year":"2021","journal-title":"J. Nephrol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/ki.2015.310","article-title":"Serial Monitoring of Anti-pla2r in Initial PLA2R-Negative Patients with Primary Membranous Nephropathy","volume":"88","author":"Ramachandran","year":"2015","journal-title":"Kidney Int."},{"key":"B79","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ekir.2017.09.001","article-title":"Temporal Association between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy","volume":"3","author":"Ramachandran","year":"2018","journal-title":"Kidney Int. Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.kint.2020.10.044","article-title":"Recurrent Membranous Nephropathy after Transplantation: Donor Antigen and HLA Converge in Defining Risk","volume":"99","author":"Robson","year":"2021","journal-title":"Kidney Int."},{"key":"B81","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-020117-043811","article-title":"Molecular Pathogenesis of Membranous Nephropathy","volume":"15","author":"Ronco","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/S0140-6736(15)60731-0","article-title":"Pathophysiological Advances in Membranous Nephropathy: Time for a Shift in Patient's Care","volume":"385","author":"Ronco","year":"2015","journal-title":"Lancet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/jcm10040607","article-title":"Advances in Membranous Nephropathy","volume":"10","author":"Ronco","year":"2021","journal-title":"J. Clin. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1681\/ASN.2014070640","article-title":"Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy","volume":"26","author":"Ruggenenti","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5527\/wjn.v9.i1.1","article-title":"Renal Transplant Recipient Seizure Practical Management","volume":"9","author":"Sawhney","year":"2020","journal-title":"World J. Nephrol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"5854710","DOI":"10.1155\/2018\/5854710","article-title":"Efficacy of Traditional Chinese Medicine Regimen Jian Pi Qu Shi Formula for Refractory Patients with Idiopathic Membranous Nephropathy: a Retrospective Case-Series Study","volume":"2018","author":"Shi","year":"2018","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"758159","DOI":"10.3389\/fphar.2021.758159","article-title":"Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources","volume":"12","author":"Singla","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"638422","DOI":"10.3389\/fphar.2021.638422","article-title":"Astragaloside II Ameliorated Podocyte Injury and Mitochondrial Dysfunction in Streptozotocin-Induced Diabetic Rats","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cbi.2017.07.011","article-title":"Betulinic Acid, Isolated from the Leaves of Syzygium Cumini (L.) Skeels, Ameliorates the Proteinuria in Experimental Membranous Nephropathy through Regulating Nrf2\/NF-\u039ab Pathways","volume":"274","author":"Sutariya","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"B91","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5527\/wjn.v10.i5.88","article-title":"Trends in Pediatric Nephrotic Syndrome","volume":"10","author":"Tamura","year":"2021","journal-title":"World J. Nephrol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"593288","DOI":"10.3389\/fimmu.2021.593288","article-title":"Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy","volume":"12","author":"Tesar","year":"2021","journal-title":"Front. Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"108904","DOI":"10.1016\/j.biopha.2019.108904","article-title":"Sanqi Oral Solution Ameliorates Renal Damage and Restores Podocyte Injury in Experimental Membranous Nephropathy via Suppression of NF\u03baB","volume":"115","author":"Tian","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11255-022-03169-6","article-title":"Efficacy and Safety of Tacrolimus Combined with Corticosteroids in Patients with Idiopathic Membranous Nephropathy: a Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"1","author":"Tian","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00441-021-03429-4","article-title":"Perspectives in Membranous Nephropathy","volume":"385","author":"Tomas","year":"2021","journal-title":"Cell Tissue Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2215\/CJN.00280121","article-title":"Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas","volume":"16","author":"Uffing","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/ki.2015.34","article-title":"Serum Anti-pla2r Antibodies Can Be Initially Absent in Idiopathic Membranous Nephropathy: Seroconversion after Prolonged Follow-Up","volume":"87","author":"van de Logt","year":"2015","journal-title":"Kidney Int."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1111\/bph.14333","article-title":"Novel Inhibitors of the Cellular Renin-Angiotensin System Components, Poricoic Acids, Target Smad3 Phosphorylation and Wnt\/\u03b2-Catenin Pathway against Renal Fibrosis","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cca.2019.11.004","article-title":"Diagnostic Efficacy of Serum Anti-phospholipase A2 Receptor Antibodies for Idiopathic Membranous Nephropathy in Patients with Diabetic Kidney Disease","volume":"502","author":"Wang","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"B101","doi-asserted-by":"publisher","first-page":"587663","DOI":"10.3389\/fphar.2020.587663","article-title":"Bu-Shen-Huo-Xue Decoction Ameliorates Diabetic Nephropathy by Inhibiting Rac1\/PAK1\/p38MAPK Signaling Pathway in High-Fat Diet\/Streptozotocin-Induced Diabetic Mice","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/ndt\/gfx295","article-title":"Rituximab for Non-responsive Idiopathic Membranous Nephropathy in a Chinese Cohort","volume":"33","author":"Wang","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"B103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/imna.imna_10_21","article-title":"Treatment of Membranoproliferative Glomerulonephritis with Traditional Chinese Medicine and Rituximab: A Case Report","volume":"8","author":"Wang","year":"2021","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"B104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/imna.imna_21_21","article-title":"Xiaochaihu Decoction in Diabetic Kidney Disease: A Study Based on Network Pharmacology and Molecular Docking Technology","volume":"8","author":"Wang","year":"2021","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"B105","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.intimp.2016.01.008","article-title":"Zhen-Wu-tang Attenuates Cationic Bovine Serum Albumin-Induced Inflammatory Response in Membranous Glomerulonephritis Rat through Inhibiting AGEs\/RAGE\/NF-\u03baB Pathway Activation","volume":"33","author":"Wu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e930097","DOI":"10.12659\/MSM.930097","article-title":"A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China","volume":"27","author":"Wu","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"B107","doi-asserted-by":"publisher","first-page":"775586","DOI":"10.3389\/fmed.2021.775586","article-title":"Patient Survival between Hemodialysis and Peritoneal Dialysis Among End-Stage Renal Disease Patients Secondary to Myeloperoxidase-ANCA-Associated Vasculitis","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","article-title":"The Genetic Architecture of Membranous Nephropathy and its Potential to Improve Non-invasive Diagnosis","volume":"11","author":"Xie","year":"2020","journal-title":"Nat. Commun."},{"key":"B109","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/ckj\/sfx128","article-title":"The Utility of Phospholipase A2 Receptor Autoantibody in Membranous Nephropathy after Kidney Transplantation","volume":"11","author":"Xipell","year":"2018","journal-title":"Clin. Kidney J."},{"key":"B110","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000507704","article-title":"Advances in Pathogenesis of Idiopathic Membranous Nephropathy","volume":"6","author":"Xu","year":"2020","journal-title":"Kidney Dis. (Basel)"},{"key":"B111","doi-asserted-by":"publisher","first-page":"624404","DOI":"10.3389\/fphar.2021.624404","article-title":"Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats with Diabetic Nephropathy by Promoting Autophagy","volume":"12","author":"Xuan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"759479","DOI":"10.3389\/fphar.2021.759479","article-title":"Signaling Potential Therapeutic Herbal Medicine Prescription for Treating COVID-19 by Collaborative Filtering","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"587995","DOI":"10.3389\/fphar.2020.587995","article-title":"Huidouba Improved Podocyte Injury by Down-Regulating NOX4 Expression in Rats with Diabetic Nephropathy","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/imna.imna_28_21","article-title":"Traditional Chinese Medicine in Ameliorating Diabetic Kidney Disease via Modulating Gut Microbiota","volume":"8","author":"Yang","year":"2021","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"B115","doi-asserted-by":"publisher","first-page":"668407","DOI":"10.3389\/fphar.2021.668407","article-title":"Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: a Review","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"13119","DOI":"10.1038\/s41598-020-70009-x","article-title":"Single-nucleotide Polymorphism Rs4664308 in PLA2R1 Gene Is Associated with the Risk of Idiopathic Membranous Nephropathy: a Meta-Analysis","volume":"10","author":"Yoshikawa","year":"2020","journal-title":"Sci. Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"579241","DOI":"10.3389\/fphar.2020.579241","article-title":"Efficacy of Chinese Herbal Injections for the Treatment of Primary Nephrotic Syndrome: a Bayesian Network Meta-Analysis of Randomized Controlled Trials","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000488728","article-title":"Response Predictors to Calcineurin Inhibitors in Patients with Primary Membranous Nephropathy","volume":"47","author":"Yu","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"860588","DOI":"10.3389\/fphar.2022.860588","article-title":"TGF-\u03b2\/Smad Signaling Pathway in Tubulointerstitial Fibrosis","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.micpath.2020.104359","article-title":"Dysbiosis of Gut Microbiota in Adult Idiopathic Membranous Nephropathy with Nephrotic Syndrome","volume":"147","author":"Zhang","year":"2020","journal-title":"Microb. Pathog."},{"key":"B121","doi-asserted-by":"publisher","first-page":"8163298","DOI":"10.1155\/2021\/8163298","article-title":"A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy","volume":"2021","author":"Zhang","year":"2021","journal-title":"J. Immunol. Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"719758","DOI":"10.3389\/fphar.2021.719758","article-title":"Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fmed.2020.00109","article-title":"Baseline Soluble Anti-erythropoietin Antibody Level Is an Independent Associated Factor for Follow-Up Erythropoietin Demand in Maintenance Dialysis Patients with End-Stage Renal Disease: a Prospective Cohort Study","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e18150","DOI":"10.1097\/MD.0000000000018150","article-title":"Clinical Observation on the Effect of Wuzhi Soft Capsule on FK506 Concentration in Membranous Nephropathy Patients","volume":"98","author":"Zhang","year":"2019","journal-title":"Med. Baltim."},{"key":"B125","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41401-019-0319-4","article-title":"Asiatic Acid Prevents Renal Fibrosis in UUO Rats via Promoting the Production of 15d-PGJ2, an Endogenous Ligand of PPAR-\u03b3","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B126","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ptr.3656","article-title":"Astragaloside IV Attenuates Complement Membranous Attack Complex Induced Podocyte Injury through the MAPK Pathway","volume":"26","author":"Zheng","year":"2012","journal-title":"Phytother. Res."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/imna.imna_22_21","article-title":"Tangshen Formula Attenuates Renal Fibrosis by Downregulating Transforming Growth Factor \u03b21\/Smad3 and LncRNA-MEG3 in Rats with Diabetic Kidney Disease","volume":"8","author":"Zhou","year":"2021","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"B128","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/0886022X.2022.2057861","article-title":"Anti-PLA2R Antibody Measured by ELISA Predicts the Risk of Vein Thrombosis in Patients with Primary Membranous Nephropathy","volume":"44","author":"Zhu","year":"2022","journal-title":"Ren. Fail"},{"key":"B129","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/imj.14446","article-title":"Effectiveness and Safety of Cyclophosphamide or Tacrolimus Therapy for Idiopathic Membranous Nephropathy","volume":"50","author":"Zou","year":"2020","journal-title":"Intern Med. J."},{"key":"B130","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41401-021-00645-0","article-title":"The Challenges and Opportunities of Traditional Chinese Medicines against COVID-19: a Way Out from a Network Perspective","volume":"42","author":"Zuo","year":"2021","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.907108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T06:48:15Z","timestamp":1653547695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.907108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":130,"alternative-id":["10.3389\/fphar.2022.907108"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.907108","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"article-number":"907108"}}